Have a personal or library account? Click to login
Solving manufacturing problems for L-carnitine-L-tartrate to improve the likelihood of successful product scale-up Cover

Solving manufacturing problems for L-carnitine-L-tartrate to improve the likelihood of successful product scale-up

Open Access
|Jan 2018

References

  1. 1. M. Nishimura, T. Tokoro, T. Takatani, N. Sato, M. Nishida, T. Hashimoto, S. Yamazaki, H. Kobayashi and T. Ono, Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine, Springerplus 4 (2015) 353-362; https://doi.org/10.1186/s40064-015-1119-z10.1186/s40064-015-1119-z
  2. 2. P. Mason, Dietary Supplements, 3rd ed., Pharmaceutical Press, London 2007.
  3. 3. J. L. Flanagan, P. A. Simmons, J. Vehige, M. D. P. Wilcox and Q. Garett, Role of carnitine in disease, Nutr. Metab. (Lond) 7 (2010) 30; https://doi.org/10.1186/1743-7075-7-3010.1186/1743-7075-7-30
  4. 4. A. Hassan, Y. Tsuda, A. Asai, K. Yokohma, K. Nakamura, T. Sujishi, H. Ohama, Y. Tsuchimoto, S. Fukunishi, U. M. Abdelaal, U. A. Arafa, A. T. Hassan, A. M. Kassem and K. Higuchi, Effects of oral L-Carnitine on liver functions after transarterial chemoembolization in intermediate-stage HCC patients, Mediators of Inflammation (2015), Article ID 608216, http://dx.doi.org/10.1155/2015/60821610.1155/2015/608216
  5. 5. T. Răşanu, M. Mehedinţi-Hâncu, M. Alexianu, T. Mehedinţi, E. Gheorghe and L. Damian, Carnitine deficiency - case report, Roman. J. Morphol Embryol. 53 (2012) 203-206.
  6. 6. C. Ulbricht (Ed.), Natural Standard Medical Conditions Reference - An Integrative Approach, Elsevier- Mosby, St. Louis, MO, 2009.
  7. 7. J. Yee, L-Carnitine for anemia in hemodialysis patients: A last resort, Clin. J. Am. Soc. Nephrol. 7 (2012) 1746-1748; https://doi.org/10.2215/CJN.0992091210.2215/CJN.09920912
  8. 8. European Pharmacopoeia, E. Council of Europe, Strasbourg 2014.
  9. 9. The United States Pharmacopeia, NF30, US Pharmacopeial Convention, Maryland 2012.
  10. 10. J. Swarbrick (Ed.), Encyclopedia of Pharmaceutical Technology, 3rd Ed., Informa Healthcare, New York 2007.
  11. 11. M. Ciper and R. Bodmeier, Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity, Eur. J. Pharm. Biopharm. 62 (2006) 178-184.10.1016/j.ejpb.2005.08.014
  12. 12. I. El-Bagory, N. Barakat, M. A. Ibrahim and F. El-Enazi, Formulation and in vitro evaluation of theophylline matrix tablets prepared by direct compression: Effect of polymer blends, Saudi Pharm. J. 20 (2012) 229-238.10.1016/j.jsps.2011.11.007
  13. 13. J. Wanga, H. Wenb and D. Desai, Lubrication in tablet formulations, Eur. J. Pharm. Biopharm. 75 (2010) 1-15.10.1016/j.ejpb.2010.01.007
  14. 14. S. Mohan, Compression physics of pharmaceutical powders: a review, Int. J. Pharm. Sci. Res.; http://dx.doi.org/10.13040/IJPSR.0975-8232.3(6).1580-9210.13040/IJPSR.0975-8232.3(6).1580-92
  15. 15. R. C. Rowe, P. J. Sheskey, W. G. Cook and M. E. Fenton, Handbook of Pharmaceutical Excipients, 7th ed., Pharmaceutical Press, London 2012.
  16. 16. Physicians’ Desk Reference (PDR), 67th Ed. PDR Network 2012-01-01, https://06833842-a-62cb3a1as-sites.googlegroups.com/site/wegvergg/ganbate/Physicians-Desk-Reference-.pdf?attachauth=ANoY7cr9vlzLOqqmfplls_9fycwkg7n4tNBeh_DDkuOFHlNLBOL8VMINpJk4TR_WXev_7EinwRSMMJZ-COja82jGaxZL6lOmx0FfjJQg93w08w7_Dh66_nSllfHShXcoqZVqYXS2lvIZCKE-90T3ohWJgU5Epl0PSiWjkE2sqedXyxB442yjE6L3hyfZYUCFIrCknK6M3O1CPPuME3MMc8JTsmvIJZ2alZTcNZcD5EU4e6EXdKSGk%3D&attredirects=0, access date July 25, 2017.
  17. 17. British Pharmacopoeia, Flowability, The Pharmaceutical Press, London 2013.
  18. 18. N. R. Jadhav, A. R. Paradkar, N. H. Salunkhe, R. S. Karade and G. G. Mane, Talc: A versatile pharmaceutical excipient, World J. Pharm. Pharmaceut. Sci. 2 (2013) 4639-3660.
  19. 19. AEROSIL® and AEROPERL® Colloidal silicon dioxide for pharmaceuticals technical information TI 1281 : https://www.aerosil.com/sites/lists/RE/DocumentsSI/TI-1281-AEROSIL-and-AEROPERLColloidal-Silicon-Dioxide-for-Pharmaceuticals-EN.pdf; access date July 25, 2017.
  20. 20. G. Ragnarsson, A. W. Hdlzer and J. Sjogren, The influence of mixing time and colloidal silica on the lubricating properties of magnesium stearate, Int. J. Pharm. 3 (1979) 127-131.10.1016/0378-5173(79)90074-7
  21. 21. G. Thoorens, F. Krier, B. Leclercq, B. Carlin and B. Evrard, Microcrystalline cellulose, a direct compression binder in a quality by design environment - A review, Int. J. Pharm. 473 (2014) 64-72.10.1016/j.ijpharm.2014.06.05524993785
  22. 22. M. Jivraj, L. G. Martini and C. M. Thomson, An overview of the different excipients useful for the direct compression of tablets, Pharmaceut. Sci. Technol. Today 3 (2000) 58-63.10.1016/S1461-5347(99)00237-0
  23. 23. L. Jinjiang and W. Yongmei, Review: Lubricants in pharmaceutical solid dosage forms, Lubricants 2 (2014) 21-43.
DOI: https://doi.org/10.1515/acph-2017-0033 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 511 - 525
Published on: Jan 11, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Aliaa A. Badawi, Mahmoud M. Hegazy, Dina Louis, Mohammed A. Eldegwy, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.